Thank you to Teva Pharmaceuticals

34 0

HD Insights thanks Teva for its ongoing support

Teva CNS is committed to continued research and development of its product portfolio and to the development of medicines aimed at meeting the specific needs of the patient communities it serves. Teva’s legacy in CNS is grounded in its commitment to ongoing collaboration with academia, medical institutions and patient advocacy groups to find innovative solutions for patients who live with chronic and debilitating diseases.

Leave a comment

Your email address will not be published. Required fields are marked *

Related Post

HD Insights Volume 5 (PDF)

November 1, 2013 0
[pdf-embedder url=”http://huntingtonstudygroup.org/wp-content/uploads/2016/05/vol-5-fall-2013.pdf”]

Meet the Funder

June 17, 2016 0
VITAL SIGNS NAME: Helen Budworth, DPhil TITLE: Senior Science Officer, California Institute for Regenerative Medicine EDUCATION: BSc, Genetics and Microbiology,…

HD Insights Volume 15 (PDF)

October 31, 2016 0
[pdf-embedder url=”http://huntingtonstudygroup.org/wp-content/uploads/2016/10/HD-Insights-Vol15-FINAL.pdf”] To read a non-PDF version of HD Insights Vol. 15, click here.

Highlights of CHDI

June 16, 2016 0
By: Lise Munsie, PhD CHDI began this year’s conference with a pre-session where members discussed what was happening at the…